AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
LISINOPRIL DIHYDRATE
27 registrations across 5 African markets— 24 active
Markets with LISINOPRIL DIHYDRATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| LISINOPRIL TABLETS (Each tablet contains Lisinopril Dihydrate 5mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| LISINOPRIL TABLETS (Each tablet contains Lisinopril Dihydrate 10 mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| LISINOPRIL TABLETS (Each tablet contains Lisinopril Dihydrate 10 mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| LISINOPRIL TABLETS (Each tablet contains Lisinopril Dihydrate 5mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| Lisinopril - 10 mg Tablets_ Tablet | 🇳🇬Nigeria | MULTIBASE PHARMA INDUSTRIES NIG. LTD | active | Oct 2030 |
| Rinosil 10 mg Tablet_ Tablet | 🇳🇬Nigeria | Maydon Pharmaceuticals Limited | active | Jun 2030 |
| ZESTRIL 10MG TABLETS | 🇬🇭Ghana | — | active | Mar 2030 |
| ZESTRIL 10MG TABLETS | 🇬🇭Ghana | — | active | Mar 2030 |
| ZESTRIL 5MG TABLETS | 🇬🇭Ghana | — | active | Mar 2030 |
| ZESTRIL 5MG TABLETS | 🇬🇭Ghana | — | active | Mar 2030 |
| ZESTRIL 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2002 |
| ZESTRIL 20MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2002 |
| ZESTRIL 5MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2002 |
| LISINOPRIL
DIHYDRATE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | MEDOCHEMIE LTD | active | — |
| LISINOPRIL
DIHYDRATE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | MEDOCHEMIE LTD | active | — |
| ZESTRIL® 20MG CP BTE (2X14) ATNAHS PHARMA comprimé , boîte de (2x14) | 🇲🇬Madagascar | ATNAHS PHARMA | active | — |
| LISINOPRIL
DIHYDRATE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | MEDOCHEMIE LTD | active | — |
| LISINOPRIL
DIHYDRATE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | PHARMA INTERNATIONAL COMPANY | active | — |
| LISINOPRIL
DIHYDRATE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | MEDOCHEMIE LTD | active | — |
| ZESTRIL® 5MG CP SEC BTE (2X14) ATNAHS PHARMA comprimé sécable, Boîte de | 🇲🇬Madagascar | ATNAHS PHARMA | active | — |
| ZESTRIL® 20MG CP BTE (2X14) ATNAHS PHARMA comprimé , boîte de (2x14) | 🇲🇬Madagascar | ATNAHS PHARMA | active | — |
| LISINOPRIL
DIHYDRATE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | PHARMA INTERNATIONAL COMPANY | active | — |
| ZESTRIL® 5MG CP SEC BTE (2X14) ATNAHS PHARMA comprimé sécable, Boîte de | 🇲🇬Madagascar | ATNAHS PHARMA | active | — |
| LISINOPRIL
DIHYDRATE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | PHARMA INTERNATIONAL COMPANY | active | — |
| GLOPRIL 10 CP BTE(1X10,10X10) GLOBAL PHARMA HEALTHCARE PVT. Comprimé, boites de 1x10 et | 🇲🇬Madagascar | GLOBAL PHARMA HEALTHCARE | active | — |
| LISINOPRIL
DIHYDRATE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | PHARMA INTERNATIONAL COMPANY | active | — |
| GLOPRIL 10 CP BTE(1X10,10X10) GLOBAL PHARMA HEALTHCARE PVT. Comprimé, boites de 1x10 et | 🇲🇬Madagascar | GLOBAL PHARMA HEALTHCARE | active | — |
LISINOPRIL DIHYDRATE in Africa — Regulatory Overview
LISINOPRIL DIHYDRATE is registered across 5 African markets with 27 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Uganda, Madagascar, Malawi and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 27 registrations, 24 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.